Haftungsausschluss: Diese Website bündelt öffentlich verfügbare Daten aus offiziellen Quellen wie FDA, ClinicalTrials.gov, PubMed und SEC EDGAR nur zur allgemeinen Information. Sie stellt keine medizinische Beratung, Diagnose, Behandlungsempfehlung oder Anlageberatung dar.

PubMed

Risk of Recall Associated With Modifications to High-risk Medical Devices Approved Through US Food and Drug Administration Supplements.

PMID: 37043202 ·

J, o, n, a, t, h, a, n, , R, , D, u, b, i, n, ;, , J, o, n, a, t, h, a, n, , R, , E, n, r, i, q, u, e, z, ;, , A, n, -, L, i, n, , C, h, e, n, g, ;, , H, u, n, t, e, r, , C, a, m, p, b, e, l, l, ;, , A, k, i, n, , C, i, l

ZeitschriftJAMA network open
Jahr
PMID37043202

Zusammenfassung

High-risk medical devices approved by the US Food and Drug Administration (FDA) can undergo modifications to their original premarket approval (PMA) via 1 of 5 types of supplements. Only panel track supplements (approximately 1%) require clinical data for approval. The association between device modifications and risk to patient safety has not previously been analyzed. To determine the association between PMA supplements and the risk of any device recall and high-risk (class 1) recall. In this c

Offizielle Quelle

Auf PubMed ansehen →

Daten aus PubMed / NCBI. Den Volltext und die aktuellsten Informationen finden Sie stets im offiziellen Eintrag.

↑